Protagenic Therapeutics, Inc. (PTIX)
NASDAQ: PTIX · Real-Time Price · USD
4.290
+0.050 (1.18%)
At close: Sep 26, 2025, 4:00 PM EDT
4.260
-0.030 (-0.70%)
After-hours: Sep 26, 2025, 7:30 PM EDT
Protagenic Therapeutics Market Cap
Protagenic Therapeutics has a market cap or net worth of $8.22 million as of September 26, 2025.
Market Cap
8.22M
Enterprise Value
8.13M
1-Year Change
n/a
Ranking
Category
Stock Price
$4.29
Market Cap Chart
Since May 19, 2025, Protagenic Therapeutics's market cap has decreased from $9.64M to $8.22M, a decrease of -14.78%. That is a compound annual growth rate of -36.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 8.22M | 1.18% |
| Sep 25, 2025 | 8.12M | 3.16% |
| Sep 24, 2025 | 7.87M | -5.52% |
| Sep 23, 2025 | 8.33M | -0.46% |
| Sep 22, 2025 | 8.37M | 7.90% |
| Sep 19, 2025 | 7.76M | 5.74% |
| Sep 18, 2025 | 7.33M | 4.08% |
| Sep 17, 2025 | 7.05M | 8.24% |
| Sep 16, 2025 | 6.51M | 1.80% |
| Sep 15, 2025 | 6.40M | 3.73% |
| Sep 12, 2025 | 6.17M | -3.01% |
| Sep 11, 2025 | 6.36M | 16.08% |
| Sep 10, 2025 | 5.48M | 120.51% |
| Sep 9, 2025 | 2.48M | 0.35% |
| Sep 8, 2025 | 2.47M | -9.52% |
| Sep 5, 2025 | 2.74M | 1.61% |
| Sep 4, 2025 | 2.69M | -4.91% |
| Sep 3, 2025 | 2.83M | -9.19% |
| Sep 2, 2025 | 3.12M | -0.28% |
| Aug 29, 2025 | 3.13M | 1.41% |
| Aug 28, 2025 | 3.08M | -8.97% |
| Aug 27, 2025 | 3.39M | -1.76% |
| Aug 26, 2025 | 3.45M | -11.97% |
| Aug 25, 2025 | 3.92M | 6.37% |
| Aug 22, 2025 | 3.68M | -0.47% |
| Aug 21, 2025 | 3.70M | 86.84% |
| Aug 20, 2025 | 1.98M | -10.94% |
| Aug 19, 2025 | 2.22M | -7.91% |
| Aug 18, 2025 | 2.41M | -5.12% |
| Aug 15, 2025 | 2.54M | -4.56% |
| Aug 14, 2025 | 2.67M | 10.43% |
| Aug 13, 2025 | 2.41M | 1.09% |
| Aug 12, 2025 | 2.39M | -1.79% |
| Aug 11, 2025 | 2.43M | -1.06% |
| Aug 8, 2025 | 2.46M | 0.35% |
| Aug 7, 2025 | 2.45M | -2.08% |
| Aug 6, 2025 | 2.50M | -5.11% |
| Aug 5, 2025 | 2.64M | 12.83% |
| Aug 4, 2025 | 2.34M | -1.10% |
| Aug 1, 2025 | 2.36M | -7.48% |
| Jul 31, 2025 | 2.55M | -7.84% |
| Jul 30, 2025 | 2.77M | 3.91% |
| Jul 29, 2025 | 2.67M | -6.40% |
| Jul 28, 2025 | 2.85M | 0.61% |
| Jul 25, 2025 | 2.83M | 0.62% |
| Jul 24, 2025 | 2.81M | -3.86% |
| Jul 23, 2025 | 2.93M | 0.90% |
| Jul 22, 2025 | 2.90M | 5.03% |
| Jul 21, 2025 | 2.76M | -7.02% |
| Jul 18, 2025 | 2.97M | -3.12% |
| Jul 17, 2025 | 3.07M | 2.32% |
| Jul 16, 2025 | 3.00M | -0.86% |
| Jul 15, 2025 | 3.02M | -2.52% |
| Jul 14, 2025 | 3.10M | -3.25% |
| Jul 11, 2025 | 3.20M | -1.34% |
| Jul 10, 2025 | 3.25M | -2.35% |
| Jul 9, 2025 | 3.33M | 11.66% |
| Jul 8, 2025 | 2.98M | 1.18% |
| Jul 7, 2025 | 2.94M | -2.02% |
| Jul 3, 2025 | 3.00M | -0.57% |
| Jul 2, 2025 | 3.02M | -1.69% |
| Jul 1, 2025 | 3.07M | -4.32% |
| Jun 27, 2025 | 3.21M | -4.39% |
| Jun 26, 2025 | 3.36M | 5.74% |
| Jun 25, 2025 | 3.18M | - |
| Jun 24, 2025 | 3.18M | 2.52% |
| Jun 23, 2025 | 3.10M | 0.28% |
| Jun 20, 2025 | 3.09M | 3.49% |
| Jun 18, 2025 | 2.99M | -2.27% |
| Jun 17, 2025 | 3.06M | 3.83% |
| Jun 16, 2025 | 2.94M | 2.11% |
| Jun 13, 2025 | 2.88M | -5.68% |
| Jun 12, 2025 | 3.06M | -0.28% |
| Jun 11, 2025 | 3.07M | -0.28% |
| Jun 10, 2025 | 3.07M | -2.75% |
| Jun 9, 2025 | 3.16M | 0.55% |
| Jun 6, 2025 | 3.14M | 3.87% |
| Jun 5, 2025 | 3.03M | -8.29% |
| Jun 4, 2025 | 3.30M | 3.54% |
| Jun 3, 2025 | 3.19M | -3.42% |
| Jun 2, 2025 | 3.30M | -1.30% |
| May 30, 2025 | 3.34M | 1.05% |
| May 29, 2025 | 3.31M | -4.75% |
| May 28, 2025 | 3.47M | 1.52% |
| May 27, 2025 | 3.42M | -17.23% |
| May 23, 2025 | 4.13M | -11.36% |
| May 22, 2025 | 4.66M | -12.54% |
| May 21, 2025 | 5.33M | -10.76% |
| May 20, 2025 | 5.97M | -38.02% |
| May 19, 2025 | 9.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 650.45B |
| Johnson & Johnson | 432.80B |
| AbbVie | 389.72B |
| UnitedHealth Group | 311.62B |
| Novo Nordisk | 242.68B |
| Novartis AG | 238.65B |
| Abbott Laboratories | 232.44B |
| AstraZeneca | 228.75B |